Not provided
Not provided
Not provided
Not provided
Not provided
slow enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an initial pilot study to test feasibility, participant engagement and satisfaction, and clinical and neurobiological target engagement of a behavioral treatment called "ASCEND" that combines computer-based cognitive training and coaching of cognitive strategies to improve daily cognitive functioning in individuals with stroke.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ASCEND | Experimental | ASCEND combines computer-based cognitive training exercises, homework exercises to enhance cognition, and coaching sessions delivered in-person and via telephone/videoconference by a neuropsychologist. ASCEND includes 24 total computer training sessions of 30 minutes each, for a total of 12 hours. ASCEND includes 8 coaching sessions of 45 minutes each. The computer exercises aim to improve attention, working memory (WM), and cognitive control through a series of engaging and interactive computer games (e.g., card games, driving simulation). The homework exercises and coaching sessions aim to assist the participant in generalizing and transferring skills from the computer exercises to daily life and to develop further strategies to compensate for attention and WM difficulties in daily life. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ASCEND | Behavioral | ASCEND is a behavioral intervention that combines computer-based cognitive exercise, strategy coaching with a neuropsychologist, and homework exercises in order to improve attention, working memory, and cognitive control after stroke. |
| Measure | Description | Time Frame |
|---|---|---|
| Participant satisfaction with ASCEND, as measured by the Client Satisfaction Questionnaire-8 (CSQ-8) | The CSQ-8 is a self-report measure of participant satisfaction with the intervention. Scores range from 8-32 with higher scores indicating greater satisfaction. | 5 weeks (at the conclusion of treatment) |
| Participant impression of ASCEND as a credible treatment to improve cognition, as measured by the Credibility and Expectancy Questionnaire (CEQ). | The CEQ is a self-report measure that assesses participants' perceived benefit and improvement from the intervention. Each item is scored on a 1-9 Likert-type scale or as a percentage rating from 0% to 100% in 10% increments. | 5 weeks (at the conclusion of treatment) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in auditory attention and working memory, as measured by the Digit Span test | Performance-based measure of attention/working memory with scores ranging from 0-48, with higher scores indicating better performance. | Baseline, 5 weeks |
| Change in visual attention and working memory, as measured by the Symbol Span test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Abhishek Jaywant, PhD | Weill Medical College of Cornell University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| NewYork-Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | 10065 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Performance-based measure of attention/working memory with scores ranging from 0-50, with higher scores indicating better performance. |
| Baseline, 5 weeks |
| Change in divided attention and working memory, as measured by the Symbol-Digit Modalities Test | Performance-based measure of divided attention/working memory with scores ranging from 0-120, with higher scores indicating better performance. | Baseline, 5 weeks |
| Change in divided attention and processing speed, as measured by the Trail Making Test | Performance-based and timed measure of divided attention/processing speed with lower scores indicating better performance (faster completion time). | Baseline, 5 weeks |
| Change in selective attention and inhibitory control, as measured by the Stroop Test | Performance-based and timed measure of selective attention and inhibition, with higher scores indicating better performance. | Baseline, 5 weeks |
| Change in rapid working memory and mental arithmetic, as measured by the Paced Auditory Serial Addition Test (PASAT) | Performance-based and timed measure of rapid working memory, with higher scores indicating better performance. | Baseline, 5 weeks |
| Change in attention and working memory as measured by the Mental Control test | Performance-based measure of simple auditory attention and working memory. Scores range from 0-12 with higher scores indicating better performance. | Baseline, 5 weeks |
| Change in executive functioning as measured by the Weekly Calendar Planning Activity | Performance-based measure of executive functioning. Higher scores indicate better performance. | Baseline, 5 weeks |
| Change in self-reported executive functioning as measured by the Behavior Rating Inventory of Executive Function-Adult | Self-report measure of executive functioning. Higher scores indicate greater problems with executive dysfunction in daily life. | Baseline, 5 weeks |
| Change in self-reported cognitive symptoms due to stroke, as measured by the Patient Reported Evaluation of Cognitive State (PRECIS). | Self-report measure of cognitive difficulties after stroke. Scores range from 0-128 with higher scores indicating greater cognitive problems in daily life due to stroke. | Baseline, 5 weeks |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |